Skip to main content

Published locations for VENUS: Ustekinumab appears superior to vedolizumab for refractory Crohn’s disease

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. VENUS: Ustekinumab appears superior to vedolizumab for refractory Crohn’s disease

User login

  • Reset your password
  • /content/venus-ustekinumab-appears-superior-vedolizumab-refractory-crohns-disease
  • /familypracticenews/article/241201/gastroenterology/venus-ustekinumab-appears-superior-vedolizumab
  • /gihepnews/article/241201/gastroenterology/venus-ustekinumab-appears-superior-vedolizumab-refractory
  • /internalmedicinenews/article/241201/gastroenterology/venus-ustekinumab-appears-superior-vedolizumab
  • /internalmedicine/article/241201/gastroenterology/venus-ustekinumab-appears-superior-vedolizumab
  • /familymedicine/article/241201/gastroenterology/venus-ustekinumab-appears-superior-vedolizumab